Defended October 18, Characterization of new breast cancer susceptibility genes with impact on prognosis and design of novel anticancer therapies. Development of a hypoxia targeted gene expression classifier in squamous cell carcinomas of the head and neck. Defended May 15, Defended June 4,
Biomedical Engineering, University of Aarhus, October Defended May 28, Defended November 18, Development of a hypoxia targeted gene expression classifier in squamous cell carcinomas of the head and neck. Image-guided adaptive radiotherapy of head and neck cancer. Influence of neoadjuvant radiotherapy on bowel, urinary, and sexual function after treatment for rectal cancer. Second primary cancers after adjuvant radiotherapy in early breast cancer patients.
Defended December 21, Hypoxia and microRNAs as biomarkers in gastroesophageal cancer. Importance of follow-up after treatment for head and neck cancer. Optimization of stereotactic body radiation therapy for metastases.
Defended October 10, Diffusion weighted MRI for radiotherapy planning. Defended April 4, Reduction of dysphagia-related morbidity in head and neck radiotherapy.
Defended November 8, Defended August 20, Defended November 19, Defended May 16, Robust treatment planning to account for variations in target position and function for RT of locally advanced prostate cancer. Defended December 13, pyd Defended October 30, Influence of tumour microenvironmental factors on endogenous markers of hypoxia.
Defended February 24, Defended November 18, Defended August 22, Dieperink, K. Defended October 9, Defended June 4, Defended November 6, Radiation-induced hypothyroidism after treatment of head-and-neck cancer. On-line adaptive radiotherapy for urinary bladder cancer to account for anatomical changes.
Defended June bmat, Defended June 28, Defended April 1, Development of a hypoxia targeted gene expression classifier in squamous cell carcinomas of the head and neck.
Defended March 19, Defended August 21, Image-guided adaptive radiotherapy of head and neck cancer.
PhD and Master’s Theses
Intensity-modulated image guided radiotherapy of bladder cancer: Defended June 25, Defended October 28, Importance of hemoglobin concentration and its modification for the outcome of head and neck cancer patients treated with radiotherapy. Intrinsic radiation resistance of mesenchymal cancer stem cells and implications for treatment response in a murine sarcoma model.
Defended May 19,